Femasys (FEMY) Construction in Progress (2020 - 2026)
Femasys' (FEMY) quarterly Construction in Progress came in at $955271.0 in Q1 2026, up 59.07% YoY from $600551.0 in Q1 2025, and up 6.39% on a QoQ basis from $897885.0 in Q4 2025.
Femasys (FEMY) Construction in Progress (2020 - 2026) Analysis & Trends
Femasys (FEMY) has 7 years of Construction in Progress data on file, last reported at $955271.0 in Q1 2026.
- Quarterly Construction in Progress rose 59.07% year-over-year to $955271.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $955271.0 (up 59.07% YoY) and the FY2025 annual result came in at $897885.0, up 17.76% from the prior year.
- Construction in Progress advanced to $955271.0 in Q1 2026, from $897885.0 in the prior quarter.
- In the past five years, Construction in Progress ranged from a high of $955271.0 in Q1 2026 to a low of $384888.0 in Q2 2023.
- A 5-year average of $567288.9 and a median of $548149.0 in 2024 frame the typical range for Construction in Progress.
- Annual changes were most pronounced in 2022 — Construction in Progress surged 204.45% — and 2023, when it dropped 21.53%.
- Tracing FEMY's Construction in Progress over 5 years: stood at $413843.0 in 2022, then advanced by 2.23% to $423077.0 in 2023, then jumped by 80.21% to $762445.0 in 2024, then climbed by 17.76% to $897885.0 in 2025, then climbed by 6.39% to $955271.0 in 2026.
- The last three Construction in Progress figures came in at $955271.0 (Q1 2026), $897885.0 (Q4 2025), and $687462.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Construction in Progress (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn | - |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn | - |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn | - |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn | - |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn | - |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | - |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | - |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | - |
| 10 | Femasys | 8.98 Mn | 7.54 Mn | 189,391.00 | 919,412.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 955,271.00 |
| Dec 31, 2025 | 897,885.00 |
| Sep 30, 2025 | 687,462.00 |
| Jun 30, 2025 | 548,426.00 |
| Mar 31, 2025 | 600,551.00 |
| Dec 31, 2024 | 762,445.00 |
| Sep 30, 2024 | 548,149.00 |
| Jun 30, 2024 | 651,157.00 |
| Mar 31, 2024 | 569,723.00 |
| Dec 31, 2023 | 423,077.00 |
| Sep 30, 2023 | 394,957.00 |
| Jun 30, 2023 | 384,888.00 |
| Mar 31, 2023 | 406,588.00 |
| Dec 31, 2022 | 413,843.00 |
| Sep 30, 2022 | 503,312.00 |
| Jun 30, 2022 | 461,735.00 |
| Mar 31, 2022 | 434,443.00 |
| Dec 31, 2021 | 379,713.00 |
| Sep 30, 2021 | 268,226.00 |
| Jun 30, 2021 | 151,662.00 |